Literature DB >> 8206532

The minimal polymorphism of class II E alpha chains is not due to the functional neutrality of mutations.

Z T Chu1, C Carswell-Crumpton, B C Cole, P P Jones.   

Abstract

Given the extensive allelic amino acid sequence polymorphism present in the first domain of A alpha, A beta, and E beta chains and its profound effects on class II function, the minimal polymorphism in the mouse E alpha chain (and in its human homologue DR alpha) is paradox. Two possible explanations for the lack of polymorphism in E alpha are: (1) the E alpha chain plays such a uniquely critical structural/functional role in antigen presentation, T-cell activation, repertoire selection, and/or pairing with E beta or other proteins for expression that it cannot vary, and mutations are selected against; (2) the E alpha chain plays a less significant role than the outer domains of other major histocompatibility complex (MHC) proteins in determining the interactions with processed peptides or with T-cell receptor (TCR), so there is no selective pressure to maintain new mutations. To explore this question we compared the ability of transfectants expressing wild type (wt) E alpha E beta d and mutant E alpha wt E beta d proteins to present peptides and bacterial superantigens to T-cell hybridomas. Mutations at the E alpha amino acid positions 31, 52, and 65&66, to residues that represent allelic alternatives in A alpha chains, significantly reduced activation of peptide-specific T hybridomas, and mutations at 71 sometimes enhanced T-cell stimulation. None of the E alpha mutations reduced, and some enhanced, superantigen stimulation of T-cell hybridomas. These results argue against the hypothesis that E alpha chains are minimally polymorphic because mutations in E alpha are functionally neutral.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206532     DOI: 10.1007/bf00163959

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  49 in total

1.  Structurally interdependent and independent regions of allelic polymorphism in class II MHC molecules. Implications for Ia function and evolution.

Authors:  N S Braunstein; R N Germain; K Loney; N Berkowitz
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

2.  High frequency of H-2E0 alleles among wild mice.

Authors:  F Figueroa; H Tichy; G Singleton; S Franguedakis-Tsolis; J Klein
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

3.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

4.  DNA sequence of the gene encoding the E alpha Ia polypeptide of the BALB/c mouse.

Authors:  J McNicholas; M Steinmetz; T Hunkapiller; P Jones; L Hood
Journal:  Science       Date:  1982-12-17       Impact factor: 47.728

5.  MHC class II haplotypes and linkage disequilibrium in primates.

Authors:  U B Gyllensten; H A Erlich
Journal:  Hum Immunol       Date:  1993-01       Impact factor: 2.850

Review 6.  The bacterial and mouse mammary tumor virus superantigens; two different families of proteins with the same functions.

Authors:  P Marrack; G M Winslow; Y Choi; M Scherer; A Pullen; J White; J W Kappler
Journal:  Immunol Rev       Date:  1993-02       Impact factor: 12.988

Review 7.  Influence of viral superantigens on V beta- and V alpha-specific positive and negative selection.

Authors:  K Tomonari; S Fairchild; O A Rosenwasser
Journal:  Immunol Rev       Date:  1993-02       Impact factor: 12.988

8.  The same MHC recombinational hot spots are active in crossing-over between wild/wild and wild/inbred mouse chromosomes.

Authors:  Y Uematsu; K Fischer Lindahl; M Steinmetz
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

9.  Regions of allelic hypervariability in the murine A alpha immune response gene.

Authors:  C O Benoist; D J Mathis; M R Kanter; V E Williams; H O McDevitt
Journal:  Cell       Date:  1983-08       Impact factor: 41.582

10.  T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.

Authors:  E W Ehrich; B Devaux; E P Rock; J L Jorgensen; M M Davis; Y H Chien
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  8 in total

1.  Allelic polymorphisms at the H-2A and HLA-DQ loci influence the response of murine lymphocytes to the Mycoplasma arthritidis superantigen MAM.

Authors:  B C Cole; A D Sawitzke; E A Ahmed; C L Atkin; C S David
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 2.  An in depth analysis of the concept of "polyspecificity" assumed to characterize TCR/BCR recognition.

Authors:  Melvin Cohn
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 3.  Learning from a contemporary history of immunology.

Authors:  Melvin Cohn
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

4.  Low MHC class II diversity in the Tasmanian devil (Sarcophilus harrisii).

Authors:  Yuanyuan Cheng; Claire Sanderson; Menna Jones; Katherine Belov
Journal:  Immunogenetics       Date:  2012-03-31       Impact factor: 2.846

5.  On the logic of restrictive recognition of peptide by the T-cell antigen receptor.

Authors:  Melvin Cohn
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

6.  Open reading frame sequencing and structure-based alignment of polypeptides encoded by RT1-Bb, RT1-Ba, RT1-Db, and RT1-Da alleles.

Authors:  Ruth A Ettinger; Antonis K Moustakas; Suzanne D Lobaton
Journal:  Immunogenetics       Date:  2004-10-23       Impact factor: 2.846

7.  Adaptive molecular evolution of the Major Histocompatibility Complex genes, DRA and DQA, in the genus Equus.

Authors:  Pauline L Kamath; Wayne M Getz
Journal:  BMC Evol Biol       Date:  2011-05-18       Impact factor: 3.260

8.  Sequence variability at three MHC loci of finless porpoises (Neophocaena phocaenoides).

Authors:  Shixia Xu; Peng Sun; Kaiya Zhou; Guang Yang
Journal:  Immunogenetics       Date:  2007-05-08       Impact factor: 3.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.